Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Nephrology Stories

2013-10-24 12:06:43

Discontinuing mycophenolate acid products does not seem to pose risks of transplant rejection Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions. Results of this study will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA. To investigate these potential links, Serban...

2013-10-23 23:28:27

Over 100 new cases filed in multidistrict litigation involving allegations of life-threatening heart problems. Resource4thePeople’s national network of attorneys continue to offer complimentary consultations to consumers responding to FDA's concerns about dialysis patients suffering heart irregularities. San Diego, CA (PRWEB) October 23, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople today announced that there has been...

2013-10-22 10:19:33

ACP's new guideline presents evidence-based recommendations for screening, monitoring, and treatment of adults with stage 1-3 chronic kidney disease The American College of Physicians (ACP) recommends against screening for chronic kidney disease (CKD) in asymptomatic adults without risk factors. ACP's new clinical practice guideline, "Screening, Monitoring, and Treatment of Stage 1-3 Chronic Kidney Disease", was published today in Annals of Internal Medicine, ACP's flagship journal....

2013-10-19 23:01:32

Filing of GranuFlo lawsuits is on the rise as serious risks alleged with GranuFlo use ST. LOUIS (PRWEB) October 19, 2013 The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. Dialysis concentrates used during dialysis treatments to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider of dialysis products. Both dialysis...

2013-10-18 12:56:36

Treatment shows promise for improving artery function Receiving dialysis at home while sleeping not only improves kidney health and quality of life for people with kidney disease, it could also decrease their risk of heart disease, says new study presented at the Canadian Cardiovascular Congress. "Patients with end-stage renal disease have at least a five-fold increase in cardiovascular complications," says Dr. Christopher Overgaard, one of the study's authors and a cardiologist at the...

2013-10-17 23:21:36

Reportbuyer.com just published a new market research report: Challenges and Opportunities: in the Renal Denervation Market. London (PRWEB) October 17, 2013 Hypertension: Prevalence and Significance Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, peripheral vascular disease, cognitive decline, damage to retinal blood vessels and visual...

2013-10-17 12:30:15

LIVE booklet to increase awareness of life-changing benefits that may be experienced with more frequent home hemodialysis therapy. LAWRENCE, Mass., Oct. 17, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the launch of a new educational booklet that outlines the documented benefits and risks of home and more frequent home hemodialysis therapy. The booklet, entitled LIVE, is designed to be used by...

2013-10-17 10:39:05

Enriched bone marrow stem cells secrete hormones in the petri dish Researchers at St. Michael's Hospital are using adult bone marrow stem cells as they investigate a completely new way of treating chronic kidney disease and heart failure in rats. Dr. Darren Yuen and Dr. Richard Gilbert were the first to show, in 2010, that enriched stem cells improved heart and kidney function in rats with both diseases. But they and other scientists wondered about the potential side effects of...

2013-10-15 23:03:09

More than 229 GranuFlo lawsuits allegedly stemming from an FDA Class I recall contend GranuFlo and NaturaLyte dialysis drugs caused patients to experience life-threatening heart side effects, including heart attack, stroke and sudden cardiac death, have been filed in the U.S. District Court, District of Massachusetts. Columbus, OH (PRWEB) October 15, 2013 More than 229 GranuFlo lawsuits pending in the U.S. District Court, District of Massachusetts, are moving into the discovery phase,...

2013-10-14 09:52:41

Treatments may help the 20 to 44 percent of patients with kidney failure who struggle with depression Behavioral therapy provided chair-side to kidney failure patients while they're undergoing dialysis may help fight depression and improve patients' quality of life, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Thanks to advances in medical technology, dialysis patients have the potential to live longer and healthier...


Latest Nephrology Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »